Back to search

Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis

Data up to Jan 2025

Published2005
Citations29
References21

Total Citations Per Year

Abstract

References (21)

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Cellular Actions of the Insulin-Like Growth Factor Binding Proteins

2002 • 1,717 citations

Cell death and control of cell survival in the oligodendrocyte lineage

1992 • 1,331 citations

Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development.

1986 • 383 citations

Diagnostic criteria for primary progressive multiple sclerosis: a position paper.

2000 • 349 citations

Diagnostic criteria for primary progressive multiple sclerosis: A position paper

2000 • 300 citations

Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination

2000 • 230 citations

Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis

2001 • 185 citations

APOE genotype is a major predictor of long-term progression of disability in MS

2001 • 176 citations

Signalling pathways involved in antiproliferative effects of IGFBP-3: a review

2001 • 168 citations

Phenotypic Manifestations of Insulin-Like Growth Factor-Binding Protein-3 Overexpression in Transgenic Mice*

2001 • 142 citations

Transferrin Is an Insulin-Like Growth Factor-Binding Protein-3 Binding Protein1

2001 • 118 citations

The role of the transferrin–transferrin-receptor system in drug delivery and targeting

2002 • 106 citations

The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis

1998 • 87 citations

Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).

1998 • 82 citations

Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review

2001 • 75 citations

IGFBP-3 and apoptosis--a license to kill?

2001 • 67 citations

Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease

2002 • 45 citations

Apolipoprotein E genotype does not influence the progression of multiple sclerosis

2003 • 44 citations

Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue

1995 • 39 citations

Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis

1998 • 25 citations

Cited By (0)

Loading...
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding… (2005) – Multiple Sclerosis Journal | Metascience Observatory Explorer